Suppression of lymphokine-activated killer induction by neutrophils.
Authors:
Open Access
- 15 December 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 141 (12) , 4395-4402
Abstract
Peripheral blood polymorphonuclear neutrophils (PMN) suppressed the induction of PBL lymphokine-activated killer (LAK) function by rIL-2 in vitro. The suppression depended on the concentration of PMN in the IL-2 culture, and required intact PMN. However, PMN did not require treatment with immunoregulators such as IL-2, LPS, or TNF to express the suppressive activity, and no direct contact with PBL was needed for the suppression. Addition of anti-TNF antibodies had no effect on the suppression, suggesting that no endogenous TNF in the culture was involved in the suppression. PMN did not inhibit LAK function by preventing utilization of IL-2 by PBL or by selective depletion of NKH-1+ cells which constitute the majority of LAK precursors in PBL. The suppression was reversed by superoxide dismutase but not by catalase, suggesting that superoxide anion, not hydrogen peroxide, was involved in the suppression. No other suppressive factor was detectable in PMN culture supernates. Our results of PMN regulating LAK induction in vitro suggest that PMN may have a role in determining the outcome of immunotherapy with IL-2 in vivo.Keywords
This publication has 36 references indexed in Scilit:
- Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functions.The Journal of Immunology, 1986
- Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase.Proceedings of the National Academy of Sciences, 1986
- In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.The Journal of Immunology, 1985
- Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.The Journal of Immunology, 1985
- In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.The Journal of Immunology, 1985
- IMPAIRMENT OF CONCANAVALIN A INDUCIBLE SUPPRESSOR ACTIVITY FOLLOWING ADMINISTRATION OF CYCLOPHOSPHAMIDE TO PATIENTS WITH ADVANCED CANCER1984
- Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.The Journal of Immunology, 1983
- Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.Journal of Clinical Investigation, 1982
- Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins.The Journal of Immunology, 1981
- Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activityJournal of Clinical Immunology, 1981